A Rationale for Treatment of Hereditary Vitamin D-resistant Rickets with Analogs of 1α,25-Dihydroxyvitamin D3
Open Access
- 1 August 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (31) , 29148-29156
- https://doi.org/10.1074/jbc.m100898200
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A Highly Sensitive Method for Large-Scale Measurements of 1,25-Dihydroxyvitamin DAnalytical Biochemistry, 1998
- Differential Interaction of α,25-Dihydroxyvitamin D3 Analogues and Their 20-epi Homologues with the Vitamin D ReceptorPublished by Elsevier ,1997
- Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness.Journal of Clinical Investigation, 1997
- Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3.Journal of Clinical Investigation, 1993
- Calcium therapy for calcitriol-resistant ricketsThe Journal of Pediatrics, 1992
- 20-EPI-vitamin D3 analogues: A novel class of potent regulators of cell growth and immune responsesBiochemical Pharmacology, 1991
- Point mutations in the Human Vitamin D Receptor Gene Associated with Hypocalcemic RicketsScience, 1988
- END-ORGAN RESISTANCE TO 1,25-DIHYDROXYCHOLECALCIFEROLThe Lancet, 1980
- Rickets with alopecia: An inborn error of vitaminD metabolismThe Journal of Pediatrics, 1979
- Vitamin-D-Dependent Rickets Type IINew England Journal of Medicine, 1978